dc.contributor.advisor | Klingenberg, Claus | |
dc.contributor.author | Jackola, Kristin Elise | |
dc.contributor.author | Karoliussen, Kristine Solstrand | |
dc.date.accessioned | 2024-05-27T06:40:39Z | |
dc.date.available | 2024-05-27T06:40:39Z | |
dc.date.issued | 2022-05-24 | |
dc.description.abstract | <p>Introduction: The association between respiratory support and lung disease is known. This study analysed the duration of different respiratory managements for preterm infants born before week 28 and between week 28-31 and preterm infants with BPD. Regional differences were also evaluated.
<p>Materials and methods: a nationwide population-based registry study, and the data is gathered from Norwegian Neonatal Network. The data obtains all live-born premature infants born between gestation age 22-31 in the given period. A total of 5296 premature infants were included.
<p>Results: A total of 1397 (85%) preterm infants born before week 28 received MV and 949 (26%) of those born between week 28-31. Among infants diagnosed with BPD 654 (92%) born before week 28 received MV and 246 (64%) born week 28-31. Infants born before 28 weeks and with BPD2 had the longest median duration on non-invasive respiratory support (p<0.001). For all other ventilation support managements, the infants with BPD3 born before 28 weeks had the longest median duration (MV p<0.001, conventional ventilation p=0.122, HFV p=0,089). West region had the shortest median duration on MV for infants born before week 28 (p<0.001) and the lowest number of infants with BPD2/3.
<p>Conclusion: This study provides evidence that non-invasive respiratory support is the most used ventilation management for all preterm infants. There were notable trends for reduced duration of MV with decreasing severity of BPD. There are a few differences between the health regions. | en_US |
dc.identifier.uri | https://hdl.handle.net/10037/33620 | |
dc.language.iso | eng | en_US |
dc.publisher | UiT Norges arktiske universitet | en_US |
dc.publisher | UiT The Arctic University of Norway | en_US |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2022 The Author(s) | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0 | en_US |
dc.rights | Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) | en_US |
dc.subject.courseID | MED-3950 | |
dc.subject | Premature infants | en_US |
dc.subject | Lung diseases | en_US |
dc.subject | BPD | en_US |
dc.subject | Steroids against BPD | en_US |
dc.subject | Health regions in Norway | en_US |
dc.title | Respiratory morbidity and therapy in very preterm infants – a population-based study from 2009-2018 | en_US |
dc.type | Master thesis | en_US |
dc.type | Mastergradsoppgave | en_US |